Minerva Neurosciences, Inc. (NERV)
4.17
+0.05
(+1.21%)
USD |
NASDAQ |
Sep 10, 16:00
4.17
0.00 (0.00%)
After-Hours: 19:17
Minerva Neurosciences Total Assets (Quarterly) : 95.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 95.09M |
| March 31, 2026 | 94.03M |
| December 31, 2025 | 97.97M |
| September 30, 2025 | 28.09M |
| June 30, 2025 | 30.42M |
| March 31, 2025 | 32.80M |
| December 31, 2024 | 37.14M |
| September 30, 2024 | 42.81M |
| June 30, 2024 | 46.29M |
| March 31, 2024 | 50.51M |
| December 31, 2023 | 56.90M |
| September 30, 2023 | 63.13M |
| June 30, 2023 | 67.14M |
| March 31, 2023 | 51.59M |
| December 31, 2022 | 55.09M |
| September 30, 2022 | 59.76M |
| June 30, 2022 | 64.96M |
| March 31, 2022 | 70.62M |
| December 31, 2021 | 77.12M |
| September 30, 2021 | 97.56M |
| June 30, 2021 | 105.32M |
| March 31, 2021 | 111.83M |
| December 31, 2020 | 59.98M |
| September 30, 2020 | 65.22M |
| June 30, 2020 | 66.17M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.79M |
| December 31, 2019 | 79.85M |
| September 30, 2019 | 110.81M |
| June 30, 2019 | 120.29M |
| March 31, 2019 | 129.80M |
| December 31, 2018 | 144.43M |
| September 30, 2018 | 150.53M |
| June 30, 2018 | 160.94M |
| March 31, 2018 | 174.47M |
| December 31, 2017 | 188.98M |
| September 30, 2017 | 193.51M |
| June 30, 2017 | 127.38M |
| March 31, 2017 | 135.31M |
| December 31, 2016 | 132.94M |
| September 30, 2016 | 141.72M |
| June 30, 2016 | 146.50M |
| March 31, 2016 | 94.43M |
| December 31, 2015 | 82.58M |
| September 30, 2015 | 89.32M |
| June 30, 2015 | 94.32M |
| March 31, 2015 | 101.85M |
| December 31, 2014 | 68.45M |
| September 30, 2014 | 73.33M |
| June 30, 2014 | 52.96M |
| March 31, 2014 | 53.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 308.39M |
| Shareholders Equity (Quarterly) | -213.30M |
| Debt to Equity Ratio | -0.3363 |
| Current Ratio | 20.14 |
| Net Debt Paydown Yield | -0.90% |